文献速递心脑血管急症重症综合管理与镇静镇痛

视神经鞘直径动态变化对甘露醇治疗自发性脑出血颅内高压的实时评估价值

[The real-time evaluation value of dynamic changes in optic nerve sheath diameter for mannitol in treating spontaneous cerebral hemorrhage with intracranial hypertension].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论床旁超声监测ONSD可无创实时反映甘露醇降颅压效果,用药1小时ΔONSD≥0.48 mm可预测短期有效(AUC 0.892)。

前瞻性自身对照试验纳入59例自发性脑出血合并颅内高压(ICP>15 mmHg、经颅脑CT诊断、行腰大池引流)成人患者,予20%甘露醇0.5 g/kg静脉输注30分钟内完成。床旁高频超声于治疗前及治疗后0.5、1、3、6、8、12小时测ONSD,同步记录有创ICP。用药后各时点ONSD与ICP均较基线显著下降,1小时ΔONSD与ΔICP正相关(r=0.695,P<0.001),降压平台期为1~6小时。1小时ΔONSD预测甘露醇有效的AUC为0.892(95%CI 0.815~0.969),最佳界值0.48 mm,敏感度88.1%、特异度81.0%。

要点

  • 自发性脑出血合并颅内高压成人患者,20%甘露醇0.5 g/kg静脉输注30分钟内完成后,床旁超声测ONSD可无创实时替代有创ICP评估降颅压效果。
  • 用药后1小时ΔONSD与ΔICP正相关(r=0.695,P<0.001),两者下降率一致性95%一致性界限-8.5%~9.1%。
  • 1小时ΔONSD≥0.48 mm预测甘露醇短期有效,AUC 0.892(95%CI 0.815~0.969),敏感度88.1%、特异度81.0%、约登指数0.691。
  • 基线ICP 15~20 mmHg亚组(32例)与>20 mmHg亚组(27例)1小时ΔONSD预测AUC分别为0.876和0.903。
  • ONSD测量重复性良好,观察者内ICC 0.935、观察者间ICC 0.912。

适用人群与场景

  • 自发性脑出血合并颅内高压成人患者,经颅脑CT诊断、行腰大池引流、ICP>15 mmHg(1 mmHg=0.133 kPa)且需甘露醇脱水治疗,收住重症医学科(石嘴山市第二人民医院,2024年3月至2025年12月)。

诊断标准与关键阈值

  • 颅内高压:经颅脑CT诊断的自发性脑出血,腰大池引流测ICP>15 mmHg(1 mmHg=0.133 kPa)且需甘露醇脱水治疗。
  • 甘露醇短期有效判定标准:用药1小时后ICP下降率≥10%。
  • ΔONSD预测界值:用药1小时后ΔONSD≥0.48 mm预测甘露醇短期有效(AUC 0.892,95%CI 0.815~0.969,敏感度88.1%、特异度81.0%、约登指数0.691)。

处置流程与药物剂量

  • 第一步:对符合纳入标准的自发性脑出血合并颅内高压成人患者,20%甘露醇按0.5 g/kg静脉输注,30分钟内完成。
  • 第二步:于治疗前及治疗后0.5、1、3、6、8、12小时,用高频床旁超声同步测量ONSD。
  • 第三步:经腰大池引流管同步记录有创ICP,观察ONSD与ICP变化趋势(降压平台期为治疗后1~6小时)。
  • 第四步:用药1小时后计算ΔONSD,ΔONSD≥0.48 mm提示甘露醇短期有效(ICP下降率≥10%)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 前瞻性自身对照临床试验,单中心,纳入59例(男35例、女24例),平均年龄(58.4±10.7)岁。
  • 用药后各时点ONSD与ICP均较基线显著下降(F值分别为25.634、28.915,均P<0.05),降压平台期为治疗后1~6小时。
  • 用药1小时ΔONSD与ΔICP正相关(r=0.695,P<0.001),两者下降率一致性95%一致性界限-8.5%~9.1%。
  • 59例中甘露醇短期治疗有效42例、无效17例;1小时ΔONSD预测有效的AUC 0.892(95%CI 0.815~0.969),最佳界值0.48 mm,敏感度88.1%、特异度81.0%、约登指数0.691。
  • 亚组分析:基线ICP 15~20 mmHg组(32例)与>20 mmHg组(27例)1小时ΔONSD预测AUC分别为0.876和0.903。
  • ONSD测量观察者内ICC 0.935、观察者间ICC 0.912。

证据类型、等级与局限

  • 证据类型:前瞻性自身对照临床试验;原文未给出证据等级或推荐强度。
  • 局限:单中心、样本量59例、自身对照设计、无对照组;原文未提及盲法及随访结局。

对床旁实践的改变

  • 对自发性脑出血合并颅内高压、已行腰大池引流的成人患者,可用床旁超声测ONSD在用药1小时后无创评估甘露醇降颅压效果,减少对有创ICP监测的依赖。
  • 用药1小时ΔONSD≥0.48 mm提示甘露醇短期有效,可作为个体化甘露醇给药的床旁量化指标。
  • 适用条件为20%甘露醇0.5 g/kg静脉输注30分钟内完成;其他剂量、给药方式及人群(如未行腰大池引流者)原文未验证。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the clinical value of dynamic bedside ultrasound monitoring of optic nerve sheath diameter (ONSD) in noninvasive and real-time evaluation of intracranial pressure (ICP)-lowering efficacy of mannitol in patients with spontaneous cerebral hemorrhage combined with intracranial hypertension, so as to provide objective bedside evidence for individualized mannitol administration.

METHODS: A prospective self-controlled clinical trial was performed. Adult patients with spontaneous cerebral hemorrhage and intracranial hypertension who were diagnosed by cranial CT, underwent lumbar drainage, and had an ICP>15 mmHg (1 mmHg=0.133 kPa) and required mannitol dehydration treatment, and were admitted to the department of critical care medicine of Shizuishan Second People's Hospital from March 2024 to December 2025 were enrolled. All subjects received intravenous infusion of 20% mannitol 0.5 g/kg, which was completed within 30 minutes. High-frequency bedside ultrasound was used to measure ONSD simultaneously before and at 0.5, 1, 3, 6, 8, and 12 hours after treatment, and invasive ICP was recorded through the lumbar drainage tube. The trend of changes in ONSD and ICP was observed before and after treatment. Pearson correlation analysis was used to analyze the correlation between decrease in ONSD (ΔONSD) and the decrease in ICP (ΔICP) at 1 hours after treatment; intraclass correlation coefficient (ICC) was adopted to assess measurement repeatability; Bland-Altman analysis was used to evaluate the consistency between ONSD reduction rate and ICP reduction rate. The effective treatment of mannitol was judged by a decrease rate of ≥10% in ICP 1 hour after treatment. The receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive efficiency of ΔONSD on the efficacy of mannitol 1 hour after treatment.

RESULTS: Among the enrolled 59 patients, 35 male and 24 were female, with a mean age of (58.4±10.7) years old. Both ONSD and ICP decreased significantly at all time points after mannitol administration compared with baseline (F values were 25.634, 28.915, respectively, both P<0.05), and the pressure-lowering plateau was observed from 1 to 6 hours post-treatment. Pearson correlation analysis showed a positive correlation between ΔONSD and ΔICP 1 hour after treatment (r=0.695, P<0.001), and their reduction rates showed favorable consistency with 95% limit of agreement ranging from -8.5% to 9.1%. Among the 59 patients, 42 were effective and 17 were ineffective in short-term treatment with mannitol. ROC curve analysis showed that the area under the curve (AUC) for predicting the efficacy of mannitol using ΔONSD at 1 hour after treatment was 0.892, with a 95% confidence interval (95%CI) of 0.815-0.969; with the optimal cut-off value of 0.48 mm, sensitivity of 88.1%, specificity of 81.0% and Youden index of 0.691. Subgroup analysis showed that AUC predicted by ΔONSD at 1 hour after treatment were 0.876 and 0.903 in subgroups with baseline ICP of 15-20 mmHg (32 cases) and >20 mmHg (27 cases), respectively. The intra-observer ICC was 0.935 and inter-observer ICC was 0.912.

CONCLUSIONS: Dynamic bedside ultrasound monitoring of ONSD can noninvasively and in real time reflect the ICP-lowering effect of mannitol, which is highly consistent with the changing trend of invasive ICP. ΔONSD≥0.48 mm at 1 hour after medication can serve as a quantitative bedside indicator to predict short-term mannitol efficacy, worthy of clinical popularization.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yan L, Wan D, Wang C, et al. [The real-time evaluation value of dynamic changes in optic nerve sheath diameter for mannitol in treating spontaneous cerebral hemorrhage with intracranial hypertension]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693969. doi:10.3760/cma.j.cn121430-20260106-00011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。